| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/29/2002 | WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY |
| 08/29/2002 | WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof |
| 08/29/2002 | WO2000037502A9 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/29/2002 | WO2000034475A9 Grnf4, a gdnf-related neurotrophic factor |
| 08/29/2002 | WO2000034474A9 Growth factor homolog zvegf3 |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 08/29/2002 | US20020120006 Administering benzyl, naphthyl acid derivatives |
| 08/29/2002 | US20020119994 LFA-1 Antagonist compounds |
| 08/29/2002 | US20020119988 Modulators of TNF-alpha signaling |
| 08/29/2002 | US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 08/29/2002 | US20020119975 Autoimmune disease; antiinflammatory agents; antiallergens; antiproliferative agents; anticancer agents |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119971 Antiinflammatory agents; skin disorders; central nervous system disorders |
| 08/29/2002 | US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor |
| 08/29/2002 | US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |
| 08/29/2002 | US20020119961 Bridged piperazine derivatives |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | US20020119946 Formative agent of protein complex |
| 08/29/2002 | US20020119926 Inhibitors of IAPP fibril formation and uses thereof |
| 08/29/2002 | US20020119924 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 08/29/2002 | US20020119504 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 08/29/2002 | US20020119452 Nucleotide sequences coding protein for use in the diagnosis and treatment of osteoarthritis |
| 08/29/2002 | US20020119185 Active substance patch, kind to the skin, for transdermal administration of nonsteroidal antirheumatics |
| 08/29/2002 | US20020119143 Antithrombin III for disorders caused by angiogenesis |
| 08/29/2002 | US20020119126 Culturing adipose stromal cells in a medium capable of supporting the growth of fibroblasts and differentiation inducing amounts of beta - glycerophosphate and ascorbic acid and/or ascorbic-2 phosphate |
| 08/29/2002 | DE10107683A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 08/29/2002 | CA2737095A1 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 08/29/2002 | CA2473197A1 Novel human protease and polynucleotides encoding the same |
| 08/29/2002 | CA2453078A1 2-thio-substituted imidazole derivatives and their use in pharmacy |
| 08/29/2002 | CA2438711A1 Tryptase inhibitors |
| 08/29/2002 | CA2438685A1 Tryptase inhibitors |
| 08/29/2002 | CA2438682A1 Antibodies that bind both bcma and taci |
| 08/29/2002 | CA2438519A1 Emulsions and aqueous dispersions of phytosterols |
| 08/29/2002 | CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | CA2438312A1 Anthrone derivatives and their use as jnk inhibitors |
| 08/29/2002 | CA2438241A1 Medicinal compositions comprising diclofenac and ornoprostil |
| 08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
| 08/29/2002 | CA2437529A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/29/2002 | CA2433348A1 Detection of compounds that modulate inflammatory responses |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/28/2002 | EP1234875A1 Novel metalloprotease having aggrecanase activity |
| 08/28/2002 | EP1234584A1 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 08/28/2002 | EP1234185A2 Pin1 as a marker for abnormal cell growth |
| 08/28/2002 | EP1234025A1 Human enzymes of the metalloprotease family |
| 08/28/2002 | EP1233981A1 G-protein coupled receptor |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233962A2 Novel heterocyclic compounds and their use as medicines |
| 08/28/2002 | EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 08/28/2002 | EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 08/28/2002 | EP1233950A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS |
| 08/28/2002 | EP1233943A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 08/28/2002 | EP1233794A1 A bioabsorbable drug delivery system |
| 08/28/2002 | EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 08/28/2002 | EP1233781A1 Assays and therapies for latent viral infection |
| 08/28/2002 | EP1233779A2 New uses of suppressive macrophage activation factors |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233772A1 Boron compounds and complexes as anti-inflammatory agents |
| 08/28/2002 | EP1233771A1 Protease inhibitors |
| 08/28/2002 | EP1233770A2 Phosphonate compounds |
| 08/28/2002 | EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 08/28/2002 | EP1123092B1 Fumaric acid microtablets |
| 08/28/2002 | CN1366524A Sulfonamide derivative as matrix metalloproteinase inhibitor |
| 08/28/2002 | CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor |
| 08/28/2002 | CN1365984A Parathyroid hormone analog and its preparing process by recombination |
| 08/28/2002 | CN1365827A Exterior-applied medicine for treating osteopathy |
| 08/28/2002 | CN1365824A Medicine for treating hyperosteogeny and bone retromorphosis and its preparing process |
| 08/28/2002 | CN1365821A Medicine 'Huwei Dan' for treating injury and gastroenteropathy |
| 08/28/2002 | CN1365783A Nano medicine 'Shangshi Zhitong' and its preparing process |
| 08/28/2002 | CN1365770A Nano medicine 'Miaoji' and its preparing process |
| 08/28/2002 | CN1365759A Nano antalgic medicine 'Zijin' and its preparing process |
| 08/28/2002 | CN1365751A Nano medicine 'Shaolin' for treating rheumatism, bone fracture and injury and its preparing process |
| 08/28/2002 | CN1365714A Nano medicine 'Jiufen' and its preparing process |
| 08/28/2002 | CN1365711A Nano vomiting nut medicine and its preparing process |
| 08/28/2002 | CN1365691A Nano medicine 'Kunming begonia' and its preparing process |
| 08/28/2002 | CN1365685A Nano medicine for reating bone fracture and injury and its preparing process |
| 08/28/2002 | CN1365673A Nano medicine 'Fengliaoxing' for treating rheumatism, bone fracture and injury and its preparing process |
| 08/28/2002 | CN1365669A Bone-building up powder |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/28/2002 | CN1089602C Medicinal composition for treatin bone fracture and its preparing process |
| 08/28/2002 | CN1089598C Traditional Chinese medical preparation for fracture setting |
| 08/27/2002 | US6441049 Administering compound effective to inhibit binding of an amyloid beta peptide with alpha-7 nicotinic acetylcholine receptors |
| 08/27/2002 | US6441032 Treating systemic lupis and multiple sclerosis |
| 08/27/2002 | US6441021 Type-iv collagenase inhibitors |
| 08/27/2002 | US6441015 Tetrazole compounds as thyroid receptor ligands |
| 08/27/2002 | US6441014 Antiinflammatory agent, useful for treating cylcoocygenase-2 associated disorders |
| 08/27/2002 | US6441012 Chemical compounds |
| 08/27/2002 | US6441010 Bi-aromatic compounds linked via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them |
| 08/27/2002 | US6441004 Monocyte chemoattractant protein-1 inhibitor compounds |
| 08/27/2002 | US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 08/27/2002 | US6440966 Benzenesulfonamide derivatives and their use as MEK inhibitors |
| 08/27/2002 | US6440958 Acrylic and propionic acid compounds, intermediates, processes, compositions, and methods |
| 08/27/2002 | US6440955 Anti-inflammatory agents |
| 08/27/2002 | US6440953 Use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. |
| 08/27/2002 | US6440937 Competitive inhibitors of trypsin-like serin proteases, especially thrombin and kininogenases such as kallikrein; thrombin inhibitors, anticoagulants, and antiinflammatory agents |
| 08/27/2002 | US6440468 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
| 08/27/2002 | US6440421 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists |